Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
33°
Snow
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about GSK plc
Recent news which mentions GSK plc
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Biogen Inc
GSK plc
Vertex Pharmaceuticals Inc
From
CNBC.com News
Cramer's Lightning Round: 'You've got a winner in Cheesecake Factory'
March 04, 2025
Tags
Business News
stocks
Stock Picks
From
CNBC.com News
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
February 04, 2025
Tags
Business News
Biotech and Pharmaceuticals
Pharmaceuticals
From
CNBC.com News
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
January 26, 2025
Tags
Business News
Pharmaceuticals
Biotech and Pharmaceuticals
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
Theravance Biopharma Inc
Pfizer Inc
Health care industry
From
CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
January 14, 2025
Tags
Healthy Returns
Dexcom Inc
Madrigal Pharmaceuticals Inc
From
CNBC.com News
Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS
November 14, 2024
Tags
Novavax Inc
GSK plc
Biontech SE
From
CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Amgen Inc
DR Horton Inc
Investment strategy
From
CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
October 17, 2024
Tags
Business News
Breaking News: Business
Pharmaceuticals
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Social issues
Health & Science
Healthy Returns
From
CNBC.com News
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
September 12, 2024
Tags
GSK plc
Pfizer Inc
Health care industry
From
CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
Tags
Breaking news
Merck & Co Inc
Moderna Inc
From
CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
Tags
Health care industry
Pfizer Inc
Peloton Interactive Inc
From
CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
June 17, 2024
Tags
Science
US: News
Health & Science
From
CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
Tags
Breaking news
Respiratory syncytial virus
Moderna Inc
From
CNBC.com News
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
June 03, 2024
Tags
Sanofi SA
Health care industry
Pharmaceuticals
From
CNBC.com News
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
May 31, 2024
Tags
US: News
Science
Biotechnology
From
CNBC.com News
Moderna says FDA delayed RSV vaccine approval to end of May
May 10, 2024
Tags
Pharmaceuticals
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
Tags
Business News
Pharmaceuticals
Biotech and Pharmaceuticals
From
CNBC.com News
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
April 09, 2024
Tags
Pharmaceuticals
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
March 26, 2024
Tags
Health care industry
Biotech and Pharmaceuticals
AstraZeneca PLC
From
CNBC.com News
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
February 29, 2024
Tags
Moderna Inc
Companies
Breaking news
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Health & Science
Nestle SA
LVMH Moet Hennessy Louis Vuitton SE
From
CNBC.com News
Cramer's Lightning Round: 'Hold off' on Kroger
February 05, 2024
Tags
Mad Money
AST SpaceMobile Inc
Markets
From
CNBC.com News
GSK posts blowout RSV vaccine sales, raises outlook as shots give big pharma a boost
January 31, 2024
Tags
GSK plc
Health care industry
Pfizer Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Qualcomm Inc
Meta Platforms Inc
Amazon/com Inc
From
CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
Tags
Johnson & Johnson
Business News
Pharmaceuticals
From
CNBC.com News
RSV vaccine from GSK shows potential to protect adults 50 to 59
October 25, 2023
Tags
Companies
Immunizations
Social issues
From
CNBC.com News
Moderna combination Covid, flu vaccine moves to final stage trial after positive data
October 04, 2023
Tags
Breaking news
Companies
Moderna Inc
From
CNBC.com News
Covid, RSV and flu vaccines are now available — here's how to decide whether to get them together
September 15, 2023
Tags
Companies
Moderna Inc
Breaking news
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.